Summary. A specific and highly sensitive radioimmunoassay was used to measure platelet-activating factor (PAF) production by preimplantation mouse embryos in vitro. Levels of PAF greater than 1 pg per embryo were not observed in 24-h culture medium from 2-cell embryos, compacted morulae or blastocysts, or in extracts from these embryos. Synthetic PAF added to embryos at the start of culture could be almost totally recovered after the incubation period, indicating negligible degradation of PAF during culture. PAF was also not detected in embryo samples using a washed rabbi t\x=req-\ platelet aggregation assay. It can be concluded that mouse embryos do not produce substantial levels of PAF, or any of the biologically active analogues of PAF detected by the assay.
Introduction
Platelet-activating factor (PAF), a phospholipid with the structure l-0-alkyl-2-0-acetyl-s«-glycero-3-phosphocholine (Hanahan et ai, 1980) , is a potent mediator of inflammation. A role for PAF in mediating uterine vascular permeability changes at sites of embryo implantation has been pro¬ posed, and is supported by a number of studies. Both human and mouse preimplantation embryos have been shown to secrete a substance with PAF-like activity which appears to be homologous to synthetic PAF (Collier et ai, 1988; Ryan et ai, 1989) . The level of production by human embryos appears to correlate with their potential for implantation and establishment of pregnancy (O'Neill et ai, 1987) . It has also been demonstrated that direct injection of PAF into the uteri of pseudo¬ pregnant rats induces a decidua-like response which is similar to that observed after embryo implantation (Acker et ai, 1989) . The implantation of mouse and rat embryos is inhibited by specific PAF antagonists (Spinks & O'Neill, 1988; Acker et ai, 1988) , and in the mouse this inhibition is due to a direct or indirect effect ofthe antagonists on the embryo (Spinks et ai, 1990 ). In addition, O'Neill et ai (1989) have shown that supplementation of human embryo cul¬ ture medium with PAF results in increased pregnancy rates, possibly by stimulation of embryo metabolism. Taken together, all these data suggest that PAF has positive autocrine effects on the early preimplantation mammalian embryo, as well as being an early embryonic signal which mediates the uterine decidual reaction at implantation. However, other workers have been unable to demonstrate PAF activity by rabbit blastocysts (Angle et ai, 1988b) , or inhibition of an implan¬ tation response in mice with PAF antagonists (Milligan & Finn, 1990 (Hanahan & Weintraub, 1985) . PAF production by human embryos has been assayed using the splenectomized mouse platelet bioassay (O'Neill et ai, 1987) . However, all these biological assays have problems of large variability within and between assays, and the need for careful control of non-specific interferences which cause platelet activation. The develop¬ ment of a specific radioimmunoassay (RIA) for PAF (Smal et ai, 1990b) (Quinn et ai, 1982) . Compacted morulae were obtained after 24-30 h of culture in drops of M16 medium (Whittingham, 1971) Extraction of samples. Frozen samples were thawed, sonicated and 240 pi were added to 900 µ chloroform/ methanol (1:2 v/v). Embryos alone were suspended in 240 µ 01% BSA/PBS before proceeding with extraction. The extraction mixture was vortexed and sonicated extensively before chloroform (300 µ ) and water (300 µ ) were added to effect phase separation. The upper phase was discarded and the lower chloroform phase was evaporated. The residue was then dissolved in ethanol, this was separated into samples and each sample was evaporated.
Quantitation by RIA. Each sample was reconstituted, with sonication, in 5 µ ethanol and 210 µ assay buffer. The PAF standard solution (01 mg/ml in aqueous ethanol, consisting of equal parts CI6-PAF and C18-PAF) was diluted in assay buffer to give standard solutions in the range 0-1 to 25 ng/ml. Sera were acid-treated (Smal el ai, 1989) to inactivate the enzyme PAF-acetylhydrolase, which hydrolyses PAF to lyso-PAF. and is known to be present in serum (Farr et ai, 1980 Initial attempts to assay directly for PAF in embryo culture medium showed that the presence of BSA in the RIA buffer interfered with the performance ofthe assay. Samples of culture medium were therefore extracted with chloroform/methanol (Bligh & Dyer, 1959) , achieving recovery rates greater than 85%.
Analysis of 24-h cultures of 2-cell embryos, compacted morulae or blastocysts, showed that PAF was not detected in the culture media from any of the embryo stages examined (Table 1) . Likewise, immunoreactive PAF could not be detected in direct extracts from the embryos (Table 1) . Calculations show that the total amount of PAF in each culture tube was below the sensitivity of the assay, being less than 26 pg per 25-45 embryos. Samples of embryo culture medium were also tested for PAF biological activity using the washed rabbit-platelet aggregation bioassay. In each case, levels of PAF were below the detectable limit of 10 pg. To determine whether inhibitors of PAF activity were present in the samples which could inhibit the response of endogenous PAF, platelets were incubated with the extract before stimulation with synthetic PAF. In all cases, the response of platelets to added PAF was similar to that of controls which contained no embryo culture medium or embryo extracts. A typical result is shown in Fig. 1 . This indicates that the inability to detect PAF biological activity in these embryo samples is not due to embryo factors which inhibit PAF activity.
Time (min) Fig. 1 . Profiles for the aggregation of rabbit washed platelets stimulated with extracts (5 µ ) followed by PAF (50 pg). C, control (ethanol); M, 2-cell embryo culture medium (10 µ ) extract; E, extract of 2-cell embryos (equivalent to 1-25 embryos).
Stability of PAF during embryo culture
To determine whether embryos produce enzymes which may degrade PAF during the culture period, culture media with or without embryos were supplemented with known concentrations of C18-PAF at the start of embryo culture. The amount of PAF remaining after 24 h culture at 37°C was determined by RIA (Table 2 ). The amount of PAF recovered in embryo-free culture medium after 24 h was identical to that added (0 h culture). The presence of embryos in the culture medium resulted in no significant decrease in PAF activity at any concentration of PAF added ( 1 -78, 712 and 17-8 ng/ml). 2-14 ± 003 2-35 ± 0-29 1-88 ± 0-07 7-95 ± 0-49 7-65 ± 019 7-20 ± 0-32 20-8 ± 0-5 20-6 ± 0-8 18-3 ± 0-8 *Stock concentration was 35-6 ± 1-6 pg/ml, determined by RIA. tValues are the mean ± s.e.m. of 4 determinations by RIA.
Discussion
The results presented in this study demonstrate that significant quantities of PAF are not produced by cultured mouse preimplantation embryos. Using a highly specific and sensitive RIA with a detection limit of 1 pg per embryo (Smal et ai, 1990b) , PAF was not observed in the embryo culture medium or in cell-associated material extracted from 2-cell embryos, compacted morulae, or blastocysts. The possibility that PAF was synthesized and secreted by preimplantation embryos, but was degraded during the culture period was tested by the ability to recover PAF which was added exogenously to the embryo cultures. No significant degradation of exogenous PAF was demonstrated by 2-cell embryos or blastocysts over a 24-h period of incubation. The possibility of intracellular metabolism of endogenous PAF could not be excluded by these experiments.
The PAF RIA described here and elsewhere (Smal et ai, 1990b ) is based on an antiserum raised to a chemically defined PAF antigen (Smal et ai, 1989) . Recent combining-site studies have shown that the antiserum is highly specific for PAF (Smal et ai, 1990a) . The immunoreactivities of PAF analogues that are likely to occur naturally are summarized in Table 3 . In brief, the antiserum is specific for (1) an ether-linked alkyl chain at carbon 1 ofthe glyceryl backbone of PAF, (2) a shortchain acyl group (2 or 3 carbons) at carbon 2, and (3) to a lesser extent for a phosphorylcholine group at carbon 3. Thus the PAF radioimmunoassay will detect, in addition to PAF itself, only the various 1-0-alkyl homologues of PAF, the 2-0-propionyl analogue, and the various Ndemethylated analogues. All of these analogues have some degree of biological activity (Braquet & Godfroid, 1987) and should therefore be detected in any measurement of'PAF'. The analogues of PAF which are not detected by the assay are the 1-0-acyl and 2-0-long-chain acyl analogues. While these are likely to occur naturally, they have little or no biological activity (Braquet & Godfroid, 1987) . The commonly occurring lipids show no cross-reactivity at concentrations up to 20µg/ml (Smal et ai, 1990a,b) . We conclude, therefore, that mouse embryos do not synthesize either PAF itself, or any of the PAF analogues that have biological activity similar to PAF. In addition to negative results in the RIA, we were unable to detect PAF activity in embryo culture media by the washed rabbit-platelet bioassay. Endogenous inhibitors of PAF activity in crude cell extracts which can mask the presence of endogenous PAF have been reported (Miwa et ai, 1987) . However, embryo extracts used in our study were found to contain no factors which inhibited platelet aggregation in the bioassay.
Our results show that the amount of PAF produced by mouse embryos after 24-h culture is less than 1 pg/embryo, using either the RIA or the bioassay. Very low levels of mouse-embryo PAF ( <40 pg/embryo) have been detected using the platelet serotonin-release bioassay (Angle et ai, 1988a) . Maximal production of PAF appeared to coincide with the morula stage of development, and was influenced by the concentration and source of human serum in the culture medium. The embryo culture methods used in these studies differ from those used by Angle et ai (1988b) but nevertheless routinely produce blastocysts which have 80-90% implantation rates after transfer to pseudopregnant foster mice (unpublished observations) . The values in the present study differ sig¬ nificantly from the previously published levels of 800-16 700 pg PAF/embryo/24 h, when measured by a rabbit whole-blood bioassay (Collier et ai, 1988) . The splenectomized mouse bioassay has also been used to quantitate embryo-derived PAF, with similar results (O'Neill et ai, 1987) . The specificity of these bioassays for PAF detection needs to be questioned, since stimulation of the many cellular components present in these assays may lead to activation of platelets. Indeed, mouse platelets appear to be unresponsive to synthetic PAF (Lañara et ai, 1982) , suggesting that the decreased platelet count in the splenectomized mouse bioassay might be mediated by factors other than PAF. Culture media of human embryos have been tested by both the splenectomized mouse bioassay and, concurrently, rabbit washed-platelet aggregation assay. PAF-activity was detected by the former but not by the latter assay (Amiel et ai, 1989) . However, there may be species differences in the production of PAF by preimplantation embryos, and the specific RIA used in this study will be useful for such an analysis.
Although our studies indicate that viable mouse embryos do not produce significant quantities of PAF or one of the biologically active analogues of PAF, the disparity between our results and those previously published may be due to a different molecular nature of embryo-derived PAF. Since no mass spectral data are available for embryo-derived PAF, the exact chemical structure is not known. While the Chromatographie and pharmacological behaviour of embryo-derived PAF indicate a PAF-like molecule (Collier et ai, 1988) , it remains possible that even a small variation from the established structure of PAF (Hanahan et ai, 1980) 
